New project aiming at the risk of relapse from melanoma patients


A joint research team of the Dept. of Systems Biology and Bioinformatics (University Rostock) and Friedrich-Alexander-University Erlangen-Nuremberg will investigate the possibilty of skin cancer (melanoma) relapse from patients after therapy. Since April 2016 the project "MelEVIR – Melanoma, Extracellular Vesicles, and Immune Response" is funded by the Ministry of Education and Research (BMBF) with an amount of 1.3 Mio €. The formal handover for the approval of funding took place in June.
Stefan Müller, Parliamentary State Secretary at the German Federal Ministry of Research, (middle) consigns the approval of funding to Prof. Dr. Julio Vera-González from the Laboratory of Systems Immunology at the Friedrich-Alexander-University Erlangen-Nuremberg (left) and Dr. Shailendra Gupta from the University of Rostock (Picture was taken by Erich Malter, Friedrich-Alexander-University Erlangen-Nuremberg)

See article